 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Jacob Painter and Lindsey Dayer.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.112 |
|
|
|
-
Dayer LE, Wagner R, King D, Lakkad M, Wilson LA, Montgomery C, Painter JT. Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease. J Pain Palliat Care Pharmacother. 2022 Dec; 36(4):223-227.
Score: 0.909
-
Dayer LE, Breckling MN, Kling BS, Lakkad M, McDade ER, Painter JT. Association of the "CDC Guideline for Prescribing Opioids for Chronic Pain" With Emergency Department Opioid Prescribing. J Emerg Med. 2019 11; 57(5):597-602.
Score: 0.731
-
Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors. Clin Breast Cancer. 2023 08; 23(6):598-619.
Score: 0.235
-
Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain. J Cancer Surviv. 2023 Feb 08.
Score: 0.230
-
Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data. J Cancer Surviv. 2023 08; 17(4):917-950.
Score: 0.227
-
Dragic L, Webb T, Chandler M, Harrington SB, McDade E, Dayer L, Painter JT. Comparing Effectiveness of Gabapentin and Pregabalin in Treatment of Neuropathic Pain: A Retrospective Cohort of Palliative Care Outpatients. J Pain Palliat Care Pharmacother. 2020 Dec; 34(4):192-196.
Score: 0.195
-
Pritchard ER, Dayer L, Belz J, Forseth B, Harrington SE, Painter JT. Effect of cannabis on opioid use in patients with cancer receiving palliative care. J Am Pharm Assoc (2003). 2020 Jan - Feb; 60(1):244-247.
Score: 0.185
-
Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Subst Use Misuse. 2019; 54(2):331-339.
Score: 0.173
-
Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations. Pain Med. 2024 Mar 01; 25(3):173-186.
Score: 0.062
-
Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. Clin J Pain. 2023 Mar 01; 39(3):107-118.
Score: 0.058
-
Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas. Curr Med Res Opin. 2022 11; 38(11):1947-1957.
Score: 0.056
-
Callaway K, Lakkad M, Painter JT, Dayer L, Oswalt AK. The Impact of Continuous Infusion Compared to Intravenous Bolus Administration of Pantoprazole on Length of Intensive Care Unit Stay in Critically Ill Patients. J Pharm Pract. 2023 Apr; 36(2):276-280.
Score: 0.052
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|